NEW YORK, April 23 (Reuters) – Swiss food group Nestle SA
may sell about 10 to 15 percent of the $11.9 billion
baby food business it is buying from Pfizer Inc to
address antitrust concerns, Bloomberg News reported on Monday.
Nestle may have to offload divisions in countries including
Australia, Thailand and Venezuela, Bloomberg said, citing people
with knowledge of the matter.
Bloomberg reported that Nestle spokesman Robin Tickle said
it was “premature to comment on and prejudge the decisions of
the regulatory authorities”.
A spokesman for Nestle could not immediately be reached for
comment by Reuters.
Nestle, the world’s biggest food company, won a high-stakes
fight for Pfizer Nutrition, which makes 85 percent of its sales
in emerging markets. The acquisition is Nestle’s biggest deal to
date.
Consumer product companies and private equity funds may be
interested in the assets, the report said.
